The pharmaceutical industry has not taken a position on the Senate’s health care bill released Thursday. The bill would eliminate a tax on drug companies, but provisions of the bill that are expected to leave millions more uninsured could hurt sales for drug companies.
Here & Now‘s Jeremy Hobson speaks with Bloomberg’s Keri Geiger (@GeigerWire) about the latest, and about a draft order on drug prices from President Trump which eases a number of regulations on the industry.
Copyright 2021 NPR. To see more, visit https://www.npr.org.